Hunter C Smith Rhythm Pharmaceuticals, Inc. (RYTM) insider trading activity

Hunter C Smith is Chief Financial Officer of RHYTHM PHARMACEUTICALS, INC.. Currently has a direct ownership of 109,929 shares of RYTM, which is worth approximately $7.01 Million. The most recent transaction as insider was on Jun 16, 2023, when has been sold 2,000 shares (Common Stock) at a price of $6.88 per share, resulting in proceeds of $13,760. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 110K

12.24% 3M change

12.24% 12M change

Total Value Held $7.01 Million

Hunter C Smith Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 16 2023	BUY Exercise of conversion of derivative security	$13,760 $6.88 p/Share	2,000 Added 3.15%	61,406 Common Stock
Feb 14 2023	SELL Open market or private sale	$18,862 $26.87 p/Share	702 Reduced 1.17%	59,406 Common Stock
Feb 11 2023	BUY Exercise of conversion of derivative security	-	2,344 Added 3.75%	60,108 Common Stock
Feb 09 2023	SELL Open market or private sale	$38,668 $27.66 p/Share	1,398 Reduced 2.36%	57,779 Common Stock
Feb 09 2023	BUY Exercise of conversion of derivative security	-	4,063 Added 6.42%	59,177 Common Stock
Dec 23 2022	SELL Bona fide gift	-	2,500 Reduced 4.34%	55,114 Common Stock
Jul 01 2022	SELL Open market or private sale	$30,792 $4.08 p/Share	7,547 Reduced 11.58%	57,614 Common Stock
Jun 30 2022	BUY Exercise of conversion of derivative security	-	25,000 Added 27.73%	65,161 Common Stock
Feb 15 2022	SELL Open market or private sale	$5,081 $6.1 p/Share	833 Reduced 2.03%	40,161 Common Stock
Feb 11 2022	BUY Exercise of conversion of derivative security	-	2,344 Added 5.41%	40,994 Common Stock
Apr 21 2021	BUY Exercise of conversion of derivative security	$34,400 $6.88 p/Share	5,000 Added 11.45%	38,650 Common Stock
Jan 19 2021	BUY Exercise of conversion of derivative security	$27,520 $6.88 p/Share	4,000 Added 10.62%	33,650 Common Stock

Also insider at

AGLE

Aeglea BioTherapeutics, Inc. Healthcare

Director

HCS

Hunter C Smith

Chief Financial Officer

Boston, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RYTM shares.

Notify only if

Value

Insider Trading

Get notified when an Rhythm Pharmaceuticals, Inc. insider buys or sells RYTM shares.

Notify only if

Operation

Value

Type

News

Receive news related to RHYTHM PHARMACEUTICALS, INC.

Track Activities on RYTM

Account